Local Therapies for the Global COVID-19 Pandemic
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…
Certara2020 年 5 月 29 日
Applying decision analysis to drug development for COVID-19 & future pandemics
This blog discusses how decision analysis approaches can help drug developers to better decisions under…
Certara2020 年 4 月 30 日
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
This webinar will explain how pricing has evolved for the rare disease drug market and…
Certara2020 年 2 月 19 日
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
Certara2020 年 1 月 17 日
Innovative Solutions for Fast-Tracking Drugs for Rare Diseases
This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…
Certara2019 年 8 月 10 日
